News | June 10, 2025
Cadila launches beta-blocker Biscado for treatment of cardiovascular diseases
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
Jeet will be a trusted partner in cardiovascular care
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as populations continue to age
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid
QUANTI clinical development program evaluated the efficacy and safety of the investigational MRI contrast agent gadoquatrane for a broad range of potential indications and in pediatric and adult patients
Subscribe To Our Newsletter & Stay Updated
